冠状动脉疾病的机会性筛查:一项尚未开发的人群健康资源
本文通过系统检索MEDLINE、Embase和SCOPUS数据库,纳入83篇研究文献,评估非心脏指征胸部CT偶然发现的冠状动脉钙化(iCAC)的临床意义。结果显示iCAC与心血管疾病事件和死亡相关,但放射科医生报告率仅31%至44%,且部分患者未接受预防性药物治疗;报告iCAC可增加指南导向药物治疗的处方。人工智能工具有望在常规胸部CT上计算Agatston评分。
要点
- 非心脏指征胸部CT偶然发现的冠状动脉钙化(iCAC)与心血管疾病事件和死亡相关。
- 放射科医生对iCAC的报告率仅31%至44%,多数病例未被诊断。
- 报告iCAC可增加指南导向药物治疗的处方,人工智能工具可可靠计算Agatston评分。
核心结论
- 常规胸部CT上偶然发现的冠状动脉钙化(iCAC)患者存在心血管疾病事件和死亡风险,但常未被诊断;在胸部CT报告中统一报告iCAC可为放射科提供早期识别高危个体的机会,并可能降低发病率和死亡率;人工智能工具已被验证可在常规胸部CT上计算Agatston评分,并最有潜力促进广泛采用。
研究设计与样本
- 系统综述:由信息专家制定MEDLINE、Embase和SCOPUS检索策略,两名评价者独立在摘要和全文水平筛选文献,从符合条件文章中提取年龄、iCAC识别率、放射科医生报告频率、对下游医疗管理的影响及iCAC与患者结局的关联等数据;从359篇独特引用中纳入83篇研究文献。
关键影像表现/征象
- 患者中iCAC的百分比范围为9%至100%。
- 31项研究测量了iCAC与心血管疾病发病率和死亡率的关联,其中29项识别出显著相关性,包括非致死性心肌梗死、致死性心肌梗死、主要不良心血管事件、心血管死亡和全因死亡。
- 在这些队列中,iCAC存在于20%至100%的患者中,但当iCAC存在时,放射科医生仅报告了31%至44%的病例。
- 在报告相关数据的研究中,18%至77%的iCAC患者未使用预防性药物。
- 12项研究报告非心脏CT上的CAC分级与心电图门控心脏CT上的Agatston评分之间具有良好一致性,10项研究证明人工智能工具可可靠地在非心脏CT上计算Agatston评分。
诊断标准与关键数值
- 非心脏指征胸部CT上偶然发现的冠状动脉钙化(iCAC)与心血管疾病事件和死亡相关,在29项研究中识别出显著相关性。
- 非心脏CT上的CAC分级与心电图门控心脏CT上的Agatston评分之间具有良好一致性(12项研究)。
- 人工智能工具可可靠地在非心脏CT上计算Agatston评分(10项研究)。
临床应用与阅片要点
- 在胸部CT报告中统一报告iCAC,可为放射科提供早期识别高危个体的机会,并可能降低发病率和死亡率。
- 报告iCAC可增加指南导向药物治疗的处方(7项研究中5项即71%报告增加),其中一项确认低密度脂蛋白水平降低。
- 人工智能工具已被验证可在常规胸部CT上计算Agatston评分,并最有潜力促进广泛采用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Coronary artery disease is the leading cause of death in the United States. At-risk asymptomatic adults are eligible for screening with electrocardiogram-gated coronary artery calcium (CAC) CT, which aids in risk stratification and management decision-making. Incidental CAC (iCAC) is easily quantified on chest CT in patients imaged for noncardiac indications; however, radiologists do not routinely report the finding.
OBJECTIVE: To determine the clinical significance of CAC identified incidentally on routine chest CT performed for noncardiac indications.
DESIGN: An informationist developed search strategies in MEDLINE, Embase, and SCOPUS, and two reviewers independently screened results at both the abstract and full text levels. Data extracted from eligible articles included age, rate of iCAC identification, radiologist reporting frequency, impact on downstream medical management, and association of iCAC with patient outcomes.
RESULTS: From 359 unique citations, 83 research publications met inclusion criteria. The percentage of patients with iCAC ranged from 9% to 100%. Thirty-one investigations measured association(s) between iCAC and cardiovascular morbidity and mortality, and 29 identified significant correlations, including nonfatal myocardial infarction, fatal myocardial infarction, major adverse cardiovascular event, cardiovascular death, and all-cause death. iCAC was present in 20% to 100% of the patients in these cohorts, but when present, iCAC was reported by radiologists in only 31% to 44% of cases. Between 18% and 77% of patients with iCAC were not on preventive medications in studies that reported these data. Seven studies measured the effect of reporting on guideline directed medical therapy, and 5 (71%) reported an increase in medication prescriptions after diagnosis of iCAC, with one confirming reductions in low-density lipoprotein levels. Twelve investigations reported good concordance between CAC grade on noncardiac CT and Agatston score on electrocardiogram-gated cardiac CT, and 10 demonstrated that artificial intelligence tools can reliably calculate an Agatston score on noncardiac CT.
CONCLUSION: A body of evidence demonstrates that patients with iCAC on routine chest CT are at risk for cardiovascular disease events and death, but they are often undiagnosed. Uniform reporting of iCAC in the chest CT impression represents an opportunity for radiology to contribute to early identification of high-risk individuals and potentially reduce morbidity and mortality. AI tools have been validated to calculate Agatston score on routine chest CT and hold the best potential for facilitating broad adoption.
引用
- Malik RF, Sun KJ, Azadi JR, et al. Opportunistic Screening for Coronary Artery Disease: An Untapped Population Health Resource. J Am Coll Radiol. 2024. PMID: 38382860. doi:10.1016/j.jacr.2024.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。